Profiling the Prognosis of Gastric Cancer Patients: Is It Worth  Correlating the Survival with the Clinical/Pathological and Molecular Features of Gastric Cancers?

<table>Clinical and pathological features of patients undergoing R0 gastrectomy for gastric adenocarcinoma 2003 to 2011 at our Department including the M/F ratio, the localization of the tumors and the surgical treatments, the stage of the diseases, the grading of the tumors, the LNR and the LNH subgroups, the cellular types and Lauren classification, along with the rate of adjuvant treatment performed in our series.</table>

The Scientific World Journal

fig1

Figure 1

Figure 1: Profiling the Prognosis of Gastric Cancer Patients: Is It Worth  Correlating the Survival with the Clinical/Pathological and Molecular Features of Gastric Cancers? 

Figure 1 | Profiling the Prognosis of Gastric Cancer Patients: Is It Worth  Correlating the Survival with the Clinical/Pathological and Molecular Features of Gastric Cancers? 